Keywords:
острое повреждение почек, контраст-индуцированная нефропатия, развития, профилактика.References
A.J. van der Molen, P. Reimer, I.A. Dekkers, G. Bongartz, M.F. Bellin, M. Bertolotto, O. Clement, G. Heinz-Peer, F. Stacul, J.A.W. Webb, H.S. Thomsen, Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR contrast medium safety committee guidelines, Eur. Radiol. 28 (7) (2018) 2856–28698
Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxicity in high-risk patients’ study of Iso-Osmolar and low-Osmolar non-ionic contrast media study investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. (2003) 348:491–9
Ando G, Cortese B, Russo F et al. Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX. J Am Coll Cardiol 2017;
Au TH, Bruckner A, Mohiuddin SM, Hilleman DE. The prevention of contrast-induced nephropathy. Ann Pharmacother. (2014) 48:1332–42.
V. Ambros, The functions of animal micrornas, Nature 431 (7006) (2004) 350–355,
Azzalini L, Candilio L, McCullough PA et al. Current risk of contrastinduced acute kidney injury after coronary angiography and intervention: a reappraisal of the literature. Can J Cardiol 2017; 33: 12 25–1228
Banda, J. et al. Risk factors and outcomes of contrastinduced nephropathy in hospitalised South Africans. S. Afr. Med. J. 106, 699–703 (2016).
Brar SS, Aharonian V, Mansukhani P et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 2014; 383: 1814–1823
B. Liu, Y. Chai, W. Guo, K. Lin, S. Chen, J. Liu, G. Sun, G. Chen, F. Song, Y. He, Y. Liang, Z. Guo, L. Lei, L. He, L. Liu, N. Tan, Y. Liu, S. Zhong, J. Chen, Microrna188 aggravates contrast-induced apoptosis by targeting srsf7 in novel isotonic contrast-induced acute kidney injury rat models and renal tubular epithelial cells, Ann Transl Med 7 (16) (2019) 378, https://doi.org/10.21037/atm.2019.07.20.
Cardoso PP. Contrast-induced nephropathy: can we better predict and prevent it? Rev Port Cardiol (Engl Ed). (2021) 40:499–500.
. Caixeta A, Nikolsky E, Mehran R. Contrast-induced nephropathy: prevention and management of high-risk patients. Indian Heart J. (2008) 60:524–31.
Cantais, A. et al. Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study. Pediatr. Nephrol. 31, 1355–1362 (2016). 47. Eng, J. et al. Comparative effect of contrast m
Eng J, Wilson RF, Subramaniam RM et al. Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 2016; 164: 417–424
Fahling M, Seeliger E, Patzak A et al. Understanding and preventing contrast-induced acute kidney injury. Nat Rev Nephrol 2017; 13: 169–180
Ferenbach DA, Bonventre JV. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat Rev Nephrol. 2015 May;11(5):264-76. doi: 10.1038/nrneph.2015.3. Epub 2015 Feb 3. PMID: 25643664; PMCID: PMC 4412815.
Furuichi K., T. Wada, Y. Iwata, S. Kokubo, A. Hara, J. Yamahana, T. Sugaya, Y. Iwakura, K. Matsushima, M. Asano, H. Yokoyama, S. Kaneko, Interleukin-1- dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury, Crit. Care Med. 34 (9) (2006) 2447–2455.
Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012; 27: 4263–4272
Goldfarb S, McCullough PA, McDermott J et al. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 2009; 84: 170–179
Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int 2015; 87: 527–534
Hart A, Weir MR, Kasiske BL. Cardiovascular risk assessment in kidney transplantation. Kidney Int 2015; 87: 527–534 13. Heyman SN, Rosen S, Khamaisi M et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010; 45: 188–195
A. Gutiérrez-Escolano, E. Santacruz-Vázquez, F. Gómez-Pérez, Dysregulated microRNAs involved in contrast-induced acute kidney injury in rat and human, Ren. Fail. 37 (9) (2015) 1498–1506, https://doi.org/10.3109/0886022x.2015. 1077322.
Khamaisi M, Raz I, Shilo V et al. Diabetes and radiocontrast media increase endothelin converting enzyme-1 in the kidney. Kidney Int 2008; 74: 91–100
Khosla N, Soroko SB, Chertow GM et al. Preexisting chronic kidney disease: a potential for improved outcomes from acute kidney injury. Clin J Am Soc Nephrol 2009; 4: 1914–1919
Kumar N, Dahri L, Brown W et al. Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1907–1913
Kwasa E.A., S. Vinayak, R. Armstrong, The role of inflammation in contrast-induced nephropathy, Br. J. Radiol. 87 (1041) (2014) 20130738, https://doi.org/ 10.1259/bjr.20130738.
Linkermann A, Heller JO, Prokai A et al. The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J Am Soc Nephrol 2013; 24: 1545–1557
Y. Liu, B. Liu, Y. Liu, S. Chen, J. Yang, J. Liu, G. Sun, W.J. Bei, K. Wang, Z. Chen, N. Tan, J. Chen, MicroRNA expression profile by next-generation sequencing in a novel rat model of contrast-induced acute kidney injury, Ann Transl Med 7 (8) (2019) 178,
Liss P, Nygren A, Revsbech NP, Ulfendahl HR. Measurements of oxygen tension in the rat kidney after contrast media using an oxygen microelectrode with a guard cathode. Adv Exp Med Biol. (1997) 411:569–76.
R.A. Machado, S. Constantino Lde, C.D. Tomasi, H.A. Rojas, F.S. Vuolo, M.F. Vitto, P.A. Cesconetto, C.T. de Souza, C. Ritter, F. Dal-Pizzol, Sodium butyrate decreases the activation of nf-κb reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy, Nephrol. Dial. Transplant. 27 (8) (2012) 3136–3140,
McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology. (2014) 271:65–73.
Mohebi R, Karimi Galougahi K, Garcia JJ, Horst J, Ben-Yehuda O, Radhakrishnan J, et al. Long-term clinical impact of contrast-associated acute kidney injury following PCI: an ADAPT-DES substudy. JACC Cardiovasc Interv. (2022) 15:753–66.
. Nossen JO, Jakobsen JA, Kjaersgaard P et al. Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function. Scand J Clin Lab Invest 1995; 55: 341–350
Nijssen EC, Nelemans PJ, Rennenberg RJ, van Ommen V, Wildberger JE. Prophylactic intravenous hydration to protect renal function from intravascular iodinated contrast material (AMACING): long-term results of a prospective, randomised, controlled trial. EClinicalMedicine. (2018) 4-5:109–16.
Rihal CS, Textor SC, Grill DE et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259–2264
Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP. The controversy of contrast-induced nephropathy with intravenous contrast: what is the risk? Am J Kidney Dis. (2020) 75:105–13.
Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart 2016; 102: 638–648
Romano G, Briguori C, Quintavalle C et al. Contrast agents and renal cell apoptosis. Eur Heart J 2008; 29: 2569–2576
Sendeski M, Patzak A, Pallone TL et al. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009; 251: 697–704
Stacul F, van der Molen AJ, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21: 2527–2541
Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol 2011; 38: 292–299
Schönenberger E, Martus P, Bosserdt M, Zimmermann E, Tauber R, Laule M, et al. Kidney injury after intravenous versus intra-arterial contrast agent in patients suspected of having coronary artery disease: a randomized trial. Radiology. (2019) 292:664–72. doi: 10.1148/radiol.2019182220, PMID: [DOI] [PubMed] [Google Scholar]
S.Q. Sun, T. Zhang, D. Ding, W.F. Zhang, X.L. Wang, Z. Sun, L.H. Hu, S.Y. Qin, L.H. Shen, B. He, Circulating microrna-188, -30a, and -30e as early biomarkers for contrast-induced acute kidney injury, J. Am. Heart Assoc. 5 (8) (2016), https:// doi.org/10. 1161/jaha.116.004138.
S.C. Sun, The non-canonical nf-κb pathway in immunity and inflammation, Nat Rev Immunol 17 (9) (2017) 545–558, https://doi.org/10.1038/ nri.2017.52
Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol. (2003) 181:1463–71.
Vanmassenhove, J., Kielstein, J., Jörres, A., & Biesen, W. V. (2017). Management of patients at risk of acute kidney injury. The Lancet, 389(10084), 2139–2151.
Vandenberghe W, Hoste E. Contrast-associated acute kidney injury: does it really exist, and if so, what to do about it? F1000 Faculty Rev. (2019) 8:753.
Waikar SS, Betensky RA, Emerson SC et al. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 2012; 23: 13–21
F. Wang, J. Yin, Z. Lu, G. Zhang, J. Li, T. Xing, S. Zhuang, N. Wang, Limb ischemic preconditioning protects against contrast-induced nephropathy via renalase, EBioMedicine 9 (2016) 356–365,
Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 2017; 28: 653 –659
Weisbord SD, Palevsky PM. Prevention of contrast-associated acute kidney injury: what should we do? Am J Kidney Dis 2016; 68: 518–521
Windpessl, M., & Kronbichler, A. (2018). Pro: Contrast-induced nephropathy—should we try to avoid contrast media in patients with chronic kidney disease? Nephrology Dialysis Transplantation, 33(8), 1317–1319.
J. Xu, L. Ma, P. Fu, Microrna-30c attenuates contrast-induced acute kidney injury by suppressing nlrp3 inflammasome, Int. Immunopharmacol. 87 (2020) 106457, ,
Y. Yao, S. Chen, M. Cao, X. Fan, T. Yang, Y. Huang, X. Song, Y. Li, L. Ye, N. Shen, Y. Shi, X. Li, F. Wang, Y. Qian, Antigen-specific cd8(+) t cell feedback activates nlrp3 inflammasome in antigen-presenting cells through perforin, Nat. Commun. 8 (2017) 154 02.
Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. (2020) 259:118379.
Q. Zhang, M.J. Lenardo, D. Baltimore, 30 years of nf-κb: a blossoming of relevance to human pathobiology, Cell 168 (1–2) (2017) 37–57, https:// doi.org/10.1016/j. cell.2016.12.012
Z. Lu, D. Cheng, J. Yin, R. Wu, G. Zhang, Q. Zhao, N. Wang, F. Wang, M. Liang, Antithrombin iii protects against contrast-induced nephropathy, EBioMedicine 17 (2017) 101–107